CRLF1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CRLF1 monoclonal antibodies for investigating cytokine receptor-like factor 1 (CRLF1) in various biological processes. CRLF1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CRLF1 is a critical component in the signaling pathways that regulate immune responses and hematopoiesis. Its proper function is essential for the development and differentiation of lymphoid cells, and dysregulation of CRLF1 has been implicated in several hematological malignancies. Understanding CRLF1 can provide insights into therapeutic targets for diseases such as acute lymphoblastic leukemia. CRLF1 plays a vital role in cell survival and differentiation pathways. Research has shown that CRLF1 signaling is particularly important during embryonic development and neuronal survival. Recent studies have highlighted CRLF1's involvement in various physiological processes, from neural development to immune system regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of CRLF1's role in human health and disease treatment strategies.